{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:11:09Z","timestamp":1778512269931,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["17POST33410474"],"award-info":[{"award-number":["17POST33410474"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM115516"],"award-info":[{"award-number":["U54GM115516"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM106391"],"award-info":[{"award-number":["P30GM106391"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL139887"],"award-info":[{"award-number":["R01 HL139887"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01 HL100398"],"award-info":[{"award-number":["U01 HL100398"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL136560"],"award-info":[{"award-number":["R01 HL136560"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cellsig.2022.110360","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T11:10:26Z","timestamp":1653131426000},"page":"110360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Decreased expression of ErbB2 on left ventricular epicardial cells in patients with diabetes mellitus"],"prefix":"10.1016","volume":"96","author":[{"given":"Joanne T.","family":"de Kay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Carver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bailey","family":"Shevenell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Kosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Tsibulnikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Certo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Ryzhov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Robich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2022.110360_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.surg.2010.07.003","article-title":"Decreased contractile response to endothelin-1 of peripheral microvasculature from diabetic patients","volume":"149","author":"Feng","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.cellsig.2022.110360_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jtcvs.2008.12.024","article-title":"Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor","volume":"138","author":"Emani","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.cellsig.2022.110360_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2011.04.039","article-title":"Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue","volume":"665","author":"Matyal","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2022.110360_bb0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.31083\/j.rcm2202038","article-title":"Clinical overview of diabetes mellitus as a risk factor for cardiovascular death","volume":"22","author":"Abuelgasim","year":"2021","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.cellsig.2022.110360_bb0025","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.athoracsur.2008.06.078","article-title":"Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery","volume":"86","author":"Halkos","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.cellsig.2022.110360_bb0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.athoracsur.2018.07.078","article-title":"Northern New England cardiovascular disease study group. Intensity of glycemic control affects long-term survival after coronary artery bypass graft surgery","volume":"107","author":"Robich","year":"2019","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.cellsig.2022.110360_bb0035","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1042\/CS20200230","article-title":"Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease","volume":"134","author":"Geissler","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.cellsig.2022.110360_bb0040","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1159\/000489622","article-title":"Neuregulin-1 promotes myocardial angiogenesis in the rat model of diabetic cardiomyopathy","volume":"46","author":"Gui","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cellsig.2022.110360_bb0045","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cyto.2018.10.007","article-title":"Decreased plasma neuregulin 4 levels are associated with peripheral neuropathy in Chinese patients with newly diagnosed type 2 diabetes: A cross-sectional study","volume":"113","author":"Yan","year":"2019","journal-title":"Cytokine."},{"key":"10.1016\/j.cellsig.2022.110360_bb0050","series-title":"Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus?","first-page":"e13206","volume":"50","author":"Kocak","year":"2020"},{"key":"10.1016\/j.cellsig.2022.110360_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2016.04.007","article-title":"Comparison of serum Neuregulin 4 (Nrg4) levels in adults with newly diagnosed type 2 diabetes mellitus and controls without diabetes","volume":"117","author":"Kang","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cellsig.2022.110360_bb0060","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00018-008-7440-8","article-title":"The epidermal growth factor receptor family: biology driving targeted therapeutics","volume":"65","author":"Wieduwilt","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2022.110360_bb0065","first-page":"H2205","article-title":"Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis","volume":"277","author":"Russell","year":"1999","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.cellsig.2022.110360_bb0070","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1158\/0008-5472.CAN-05-3387","article-title":"Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors","volume":"66","author":"Amin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2022.110360_bb0075","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1038\/sj.onc.1203685","article-title":"Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis","volume":"19","author":"Yen","year":"2000","journal-title":"Oncogene."},{"key":"10.1016\/j.cellsig.2022.110360_bb0080","series-title":"ErbB Family Members in Human Pulmonary Microvascular Endothelial Cells Respond Differently when Exposed to Hypoxia","first-page":"845.11","volume":"33","author":"Regan","year":"2019"},{"key":"10.1016\/j.cellsig.2022.110360_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yjmcc.2017.12.013","article-title":"ErbB2 promotes endothelial phenotype of human left ventricular epicardial highly proliferative cells (eHiPC)","volume":"115","author":"Ryzhov","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.cellsig.2022.110360_bb0090","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1177\/0271678X20984976","article-title":"ErbB3 is a critical regulator of cytoskeletal dynamics in brain microvascular endothelial cells: implications for vascular remodeling and blood-brain-barrier modulation","volume":"41","author":"Wu","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cellsig.2022.110360_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00418-010-0706-x","article-title":"Combined immunoelectron microscopic and computer-assisted image analyses to detect advanced glycation end-products in human myocardium","volume":"134","author":"Donaldson","year":"2010","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.cellsig.2022.110360_bb0100","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cellsig.2022.110360_bb0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/jpet.111.190835","article-title":"Role of A2B adenosine receptors in regulation of paracrine functions of stem cell antigen 1-positive cardiac stromal cells","volume":"341","author":"Ryzhov","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2022.110360_bb0110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.0000012203.21416.14","article-title":"Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation","volume":"90","author":"Feoktistov","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.cellsig.2022.110360_bb0115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1124\/jpet.106.114850","article-title":"Role of adenosine receptors in the regulation of angiogenic factors and neovascularization in hypoxia","volume":"320","author":"Ryzhov","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2022.110360_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117634","article-title":"High ErbB3 activating activity in human blood is not due to circulating neuregulin-1 beta","volume":"251","author":"Boateng","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.cellsig.2022.110360_bb0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4161\/cbt.5.6.2708","article-title":"Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells","volume":"5","author":"Liu","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cellsig.2022.110360_bb0130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cvr\/cvq292","article-title":"C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment","volume":"89","author":"Gambini","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cellsig.2022.110360_bb0135","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/1933719108322429","article-title":"Endoglin (CD105) expression in the human heart throughout gestation: an immunohistochemical study","volume":"15","author":"Valeria","year":"2008","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.cellsig.2022.110360_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158745","article-title":"Human cardiac mesenchymal stromal cells with CD105+CD34- phenotype enhance the function of post-infarction heart in mice","volume":"11","author":"Czapla","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2022.110360_bb0145","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1038\/s41598-019-39571-x","article-title":"Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization","volume":"9","author":"Tor\u00e1n","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2022.110360_bb0150","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2022.110360_bb0155","series-title":"Origins of Cardiac Fibroblasts","first-page":"1304","volume":"107","author":"Zeisberg","year":"2010"},{"key":"10.1016\/j.cellsig.2022.110360_bb0160","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/jcmm.13111","article-title":"Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG-1\/ErbB-PI3K\/Akt\/mTOR pathway","volume":"21","author":"Wang","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cellsig.2022.110360_bb0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/jcbfm.2008.94","article-title":"Neuregulin-1 signaling in brain endothelial cells","volume":"29","author":"Lok","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cellsig.2022.110360_bb0170","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/ATVBAHA.121.315957","article-title":"Nrg1\u03b2 released in remote ischemic preconditioning improves myocardial perfusion and decreases ischemia\/reperfusion injury via ErbB2-mediated Rescue of Endothelial Nitric Oxide Synthase and Abrogation of Trx2 autophagy","volume":"41","author":"Kundumani-Sridharan","year":"2021","journal-title":"Atertio. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cellsig.2022.110360_bb0175","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/jnc.13374","article-title":"Neuregulin1-\u03b2 decreases interleukin-1\u03b2-induced RhoA activation, myosin light chain phosphorylation, and endothelial hyperpermeability","volume":"136","author":"Wu","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cellsig.2022.110360_bb0180","first-page":"853","article-title":"Endothelial dysfunction in diabetes mellitus","volume":"3","author":"Hadi","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.cellsig.2022.110360_bb0185","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.2337\/dc11-s239","article-title":"Endothelial dysfunction in diabetes: the role of reparatory mechanisms","volume":"34","author":"Avogaro","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cellsig.2022.110360_bb0190","first-page":"363","article-title":"High glucose concentrations increase endothelial cell permeability via activation of protein kinase","volume":"81","author":"Hempel","year":"1997","journal-title":"C&#x3b1"},{"key":"10.1016\/j.cellsig.2022.110360_bb0195","series-title":"High Glucose&#x2013;Induced Apoptosis in Human Endothelial Cells Is Mediated by Sequential Activations of c-Jun NH<sub>2<\/sub>-Terminal Kinase and Caspase-3","first-page":"2618","volume":"101","author":"Ho","year":"2000"},{"key":"10.1016\/j.cellsig.2022.110360_bb0200","series-title":"High Glucose Induces Human Endothelial Cell Apoptosis Through a Phosphoinositide 3-Kinase&#x2013;Regulated Cyclooxygenase-2 Pathway","first-page":"539","volume":"25","author":"Sheu","year":"2005"},{"key":"10.1016\/j.cellsig.2022.110360_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130568","article-title":"Neuregulin 1 Improves Glucose Tolerance in db\/db Mice","volume":"10","author":"Ennequin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2022.110360_bb0210","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/13813455.2018.1534243","article-title":"Neuregulin 1 treatment improves glucose tolerance in diabetic db\/db mice, but not in healthy mice","volume":"126","author":"Ennequin","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.cellsig.2022.110360_bb0215","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41598-017-02029-z","article-title":"Neuregulin 1 improves complex 2-mediated mitochondrial respiration in skeletal muscle of healthy and diabetic mice","volume":"7","author":"Ennequin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2022.110360_bb0220","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cardfail.2017.08.456","article-title":"Chronic Neuregulin-1\u03b2 treatment mitigates the progression of Postmyocardial infarction heart failure in the setting of type 1 diabetes mellitus by suppressing myocardial apoptosis, fibrosis, and key oxidant-producing enzymes","volume":"23","author":"Gupte","year":"2017","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.cellsig.2022.110360_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2840-12-52","article-title":"Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1\u03b2\/ErbB in response to myocardial infarction resulting in worsening heart failure","volume":"12","author":"Odiete","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cellsig.2022.110360_bb0230","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1096\/fj.201600428R","article-title":"Profibrotic up-regulation of glucose transporter 1 by TGF-\u03b2 involves activation of MEK and mammalian target of rapamycin complex 2 pathways","volume":"30","author":"Andrianifahanana","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2022.110360_bb0235","article-title":"Neuregulin-1 triggers GLUT4 translocation and enhances glucose uptake independently of insulin receptor substrate and ErbB3 in neonatal rat cardiomyocytes","volume":"1867","author":"Heim","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2022.110360_bb0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13058-016-0795-0","article-title":"The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis","volume":"18","author":"Wellberg","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cellsig.2022.110360_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023205","article-title":"Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo","volume":"6","author":"Young","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2022.110360_bb0250","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1016\/S0021-9258(18)42407-6","article-title":"Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses","volume":"267","author":"Spivak-Kroizman","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2022.110360_bb0255","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1093\/emboj\/19.17.4632","article-title":"Extracellular domains drive homo- but not hetero-dimerization of erbB receptors","volume":"19","author":"Ferguson","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2022.110360_bb0260","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110360_bb0265","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.trecan.2022.02.003","article-title":"Insights on ErbB glycosylation \u2013 contributions to precision oncology","volume":"8","author":"Duarte","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cellsig.2022.110360_bb0270","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1038\/s41598-022-07549-x","article-title":"Chen X and she Y-q. serum ErbB2 concentration positively correlated to the glycemic variations in newly diagnosed type 2 diabetic patients","volume":"12","author":"Huang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2022.110360_bb0275","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12967-020-02292-1","article-title":"Association between serum HER2\/ErbB2 levels and coronary artery disease: a case\u2013control study","volume":"18","author":"Jian","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2022.110360_bb0280","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2337\/dc18-2556","article-title":"Circulating HER2\/ErbB2 levels are associated with increased incidence of diabetes: A population-based cohort study","volume":"42","author":"Muhammad","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cellsig.2022.110360_bb0285","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/ijms18112262","article-title":"Gastric Cancer cell glycosylation as a modulator of the ErbB2 oncogenic receptor","volume":"18","author":"Duarte","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2022.110360_bb0290","series-title":"A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation","first-page":"14623","volume":"112","author":"Goth","year":"2015"},{"key":"10.1016\/j.cellsig.2022.110360_bb0295","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbagen.2008.03.004","article-title":"Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme","volume":"1780","author":"Escrevente","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2022.110360_bb0300","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbrc.2008.11.150","article-title":"Palmitate alters neuregulin signaling and biology in cardiac myocytes","volume":"379","author":"Miller","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2022.110360_bb0305","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbrc.2005.08.088","article-title":"Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes","volume":"336","author":"Miller","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2022.110360_bb0310","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s12282-019-00967-2","article-title":"Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy","volume":"26","author":"Lee","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.cellsig.2022.110360_bb0315","series-title":"Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2\u2013Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial","first-page":"1421","volume":"35","author":"Sonnenblick","year":"2017"},{"key":"10.1016\/j.cellsig.2022.110360_bb0320","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.18632\/oncotarget.1955","article-title":"ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer","volume":"5","author":"Feldinger","year":"2014","journal-title":"Oncotarget."},{"key":"10.1016\/j.cellsig.2022.110360_bb0325","first-page":"5","article-title":"The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction","volume":"3","author":"Akhtar","year":"2013","journal-title":"Bioimpacts."},{"key":"10.1016\/j.cellsig.2022.110360_bb0330","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.3640","article-title":"ADAM10 inhibition improves survival and augments cardiac function after myocardial infarction","volume":"41","author":"Klapproth","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cellsig.2022.110360_bb0335","first-page":"62","article-title":"Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment","volume":"106","author":"Azevedo","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.cellsig.2022.110360_bb0340","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.stemcr.2017.04.015","article-title":"Cardiosphere-derived cells require Endoglin for paracrine-mediated angiogenesis","volume":"8","author":"Redgrave","year":"2017","journal-title":"Stem Cell Rep."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682200122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682200122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:25:40Z","timestamp":1778509540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682200122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":68,"alternative-id":["S089865682200122X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110360","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased expression of ErbB2 on left ventricular epicardial cells in patients with diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110360"}}